ArticleAdvances in therapy2026

Correction: Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis.

Elena Cortés-Vicente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.